Literature DB >> 8177274

Tumor-induced osteomalacia--unveiling a new hormone.

M J Econs, M K Drezner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8177274     DOI： 10.1056/NEJM199406093302310

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  45 in total

Review 1.  Hypophosphatemic rickets.

Authors:  L A DiMeglio; M J Econs
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Characterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide107-139 as a substrate and osteocalcin, PPi and phosphate as inhibitors.

Authors:  G Boileau; H S Tenenhouse; L Desgroseillers; P Crine
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

Review 3.  Hereditary disorders of renal phosphate wasting.

Authors:  Amir S Alizadeh Naderi; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2010-10-05       Impact factor: 28.314

4.  Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.

Authors:  C P Williams; D F Child; P R Hudson; G K Davies; M G Davies; R John; P S Anandaram; A R De Bolla
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

5.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

6.  Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cells.

Authors:  Theresa J Berndt; Bernhard Bielesz; Theodore A Craig; Peter J Tebben; Desa Bacic; Carsten A Wagner; Stephen O'Brien; Susan Schiavi; Jurg Biber; Heini Murer; Rajiv Kumar
Journal:  Pflugers Arch       Date:  2005-09-09       Impact factor: 3.657

Review 7.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 8.  Recent advances in renal phosphate handling.

Authors:  Emily G Farrow; Kenneth E White
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 9.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

10.  FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.

Authors:  Jyothsna Gattineni; Carlton Bates; Katherine Twombley; Vangipuram Dwarakanath; Michael L Robinson; Regina Goetz; Moosa Mohammadi; Michel Baum
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.